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Bioluminescence imagingMultiple sclerosis is a devastating demyelinating disease of the central nervous system (CNS) in which endogenous
remyelination, and thus recovery, often fails. Although the cuprizonemousemodel allowedelucidationofmanymo-
lecular factors governing remyelination, currently very little is knownabout the spatial origin of the oligodendrocyte
progenitor cells that initiate remyelination in this model. Therefore, we here investigated in this model whether
subventricular zone (SVZ) neural stem/progenitor cells (NSPCs) contribute to remyelination of the splenium follow-
ing cuprizone-induced demyelination. Experimentally, from the day of in situNSPC labeling, C57BL/6Jmicewere fed
a 0.2% cuprizone diet during a 4-week period and then left to recover on a normal diet for 8 weeks. Two in situ la-
beling strategies were employed: (i) NSPCs were labeled by intraventricular injection of micron-sized iron oxide
particles and then followed up longitudinally by means of magnetic resonance imaging (MRI), and (ii) SVZ NSPCs
were transduced with a lentiviral vector encoding the eGFP and Luciferase reporter proteins for longitudinal mon-
itoring bymeans of in vivo bioluminescence imaging (BLI). In contrast to preceding suggestions, nomigration of SVZ
NSPC towards the demyelinated spleniumwas observed using bothMRI and BLI, and further validated by histolog-
ical analysis, thereby demonstrating that SVZ NSPCs are unable to contribute directly to remyelination of the
splenium in the cuprizone model. Interestingly, using longitudinal BLI analysis and conﬁrmed by histological anal-
ysis, an increased migration of SVZ NSPC-derived neuroblasts towards the olfactory bulb was observed following
cuprizone treatment, indicative for a potential link between CNS inﬂammation and increased neurogenesis.
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Multiple sclerosis (MS) is the most common demyelinating disease
of the central nervous system (CNS). Currently, therapeutic interven-
tions are mainly focused on halting or modulating peripheral and CNS
immune responses, while only limited research is undertaken towards
promoting endogenous repair mechanisms. The latter can be ascribed
to the original thoughts that damaged CNS tissue could not be repaired,
as neurogenesis was only seen to occur during development. However,
due to the discovery of neural stem/progenitor cells (NSPCs) in the adult
brain, stimulation of endogenous remyelination processes is emerging
as an important therapeutic goal in the treatment of MS (Franklin and
Ffrench-Constant, 2008; Menn et al., 2006), as it is well-recognized
that endogenous remyelination appears to fail in about 60% of MS
lesions (Barkhof et al., 2003). Possible reasons for the latter have most
often been studied in animal models for MS. More speciﬁcally, the
cuprizonemouse model, a toxin-inducedmurinemodel for MSwithoutnse.
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is increasingly used to elucidate factors which contribute to de- and
remyelination in MS. During the past decade, the sequence of events
during de- and remyelination in the cuprizonemodel, as well as the ac-
companying molecular and inﬂammatory events in the CNS, have been
characterized extensively (Kipp et al., 2009). In this model, cuprizone
treatment induces selective oligodendrocyte apoptosis resulting in de-
myelination of the CNSmain white matter tracts in the corpus callosum
(CC), external capsule and striatum. Moreover, demyelination can also
be observed in the cortex and hippocampus, albeit at a later time-
point (Skripuletz et al., 2011).
Following acute cuprizone-induced demyelination (i.e. 4–6 weeks of
cuprizone treatment), remyelination occurs spontaneously. In this con-
text, Petratos et al. (2004) have demonstrated the presence of a sub-
group of NG2+ oligodendroglial progenitor cells (OPCs) in the area
surrounding the plaques and in the subventricular zone (SVZ) of MS
patients. As the same observation was made in the SVZ and in the
CC of mice that were treated with cuprizone for 3 weeks, it was
suggested that progenitor cells proliferate in the SVZ and subse-
quently migrate towards the adjacent CC where they differentiate
into mature oligodendrocytes (Petratos et al., 2004). Another
study by Mason et al. Mason et al. (2000) clearly demonstrated
that cell proliferation in the SVZ occurs before the re-appearance
of mature oligodendrocytes in the CC. By performing histological
analyses at different time points they initially observed the appear-
ance of NG2+ OPCs in the fornix, after which these NG2+ OPCs
appeared to migrate into the overlaying CC (Mason et al., 2000). Ad-
ditionally, increased proliferation of SVZ NSPCs following 3–
6 weeks of cuprizone administration has been reported multiple
times by means of histological analysis (Chen et al., 2012; Kipp
et al., 2009; Mason et al., 2000). Taken together, this suggests an ex-
treme plasticity of the SVZ NSPCs during injury and repair of the
CNS.
Current non-invasive imaging modalities for longitudinal track-
ing of SVZ NSPC migration include magnetic resonance imaging
(MRI) and bioluminescence imaging (BLI) (Couillard-Despres and
Aigner, 2011; Couillard-Despres et al., 2011; Vande Velde et al.,
2012a). For MRI-based cell tracking, numerous studies reported suc-
cessful in situ labeling of SVZ NSPCs following injection of iron oxide
particles in the lateral ventricle (Panizzo et al., 2009; Shapiro et al.,
2006; Sumner et al., 2009; Vreys et al., 2010) or the SVZ (Nieman
et al., 2010). Although only a minor fraction of the injected iron
oxide particles becomes internalized by SVZ NSPCs, migration of
SVZ NSPC-derived neuroblasts along the rostral migratory stream
(RMS) towards the olfactory bulb (OB) could be monitored longitu-
dinally by means of MRI. Moreover, using this technique, a deviation
of the steady state RMS migration pathway was demonstrated for
SVZ NSPC-derived cells following a hypoxic–ischemic insult (Yang
et al., 2009). For BLI-based cell tracking, transduction of the SVZ
with a lentiviral vector (LVv) encoding the ﬁreﬂy luciferase (fLuc)
reporter protein has been applied successfully to monitor in vivo pro-
liferation and migration of SVZ NSPCs towards the OB (Reumers
et al., 2008). Given the advantage of longitudinal assessment of
in vivo SVZ NSPC behavior over single-time point histological analy-
sis, we applied two non-invasive imaging techniques (MRI and BLI)
to study the in vivo SVZ NSPC behavior and migration following de-
myelination in the cuprizone model.
Using this experimental approach, we aimed to investigate:
(i) whether or not SVZ NSPC contribute to the spontaneous endoge-
nous remyelination of the splenium that occurs in cuprizone model
of CNS de/remyelination, and (ii) whether inﬂammatory and neuro-
de/regenerative processes occurring in the cuprizone model inﬂu-
ence the steady state SVZ NSPC-derived neuroblast migration
along the RMS towards the OB. In addition, histological analyses
are applied to conﬁrm our non-invasive imaging observations at
the study end.Materials and methods
Animals
Female wild type C57BL/6J mice, 8 weeks of age, were obtained via
Charles River Laboratories (strain code 027) and used for MRI experi-
ments (n = 16). Female C57BL/6J-Tyrc-2J/J mice (albino C57BL/6J
mice) were obtained via Jackson Laboratories (strain code 000058)
and further bred in the animal facility of the University of Antwerp.
Female offspring of C57BL/6J-Tyrc-2J/J mice, 8 weeks of age, were then
used for BLI experiments (n = 20). For all experiments, mice were
kept in normal day–night cycle (12/12) with ad libitum access to food
and water. All experimental procedures were approved by the Ethics
Committee for Animal Experiments of the University of Antwerp
(approval nos. 2006/36 and 2011/13).
Induction of CNS inﬂammation, demyelination and remyelination
Female C57BL/6J (n = 10) and C57BL/6J-Tyrc-2J/J mice (n = 10),
8 weeks of age, had ad libitum access to standard rodent lab chow
mixed with 0.2% w/w cuprizone (bis(cyclohexanone)oxaldihydrazone,
Sigma-Aldrich, Germany) for 4 weeks to induce inﬂammation and
demyelination in the CNS. Following a 4 week 0.2% w/w cuprizone
diet, mice were allowed to recover for 8 weeks with ad libitum access
to standard rodent lab chow. Age matched female control C57BL6
mice (n = 6) and C57BL/6J-Tyrc-2J/J mice (n = 10) had ad libitum ac-
cess to standard rodent lab chow during the whole study period.
Preparation of the MPIO–PLL transfection complex
As an MR contrast agent to label SVZ NSPCs, 1.63 μm diameter
polystyrene/divinylbenzene-coated ﬂuorescent (Glacial Blue) micron-
sized iron oxide particles (MPIOs, 3.00 mg Fe/ml; Bangs Laboratories,
Fishers, IN, USA, #ME04F/7833) were used. A cationic polyamine non-
viral transfection agent, poly-L-lysine hydrobromide (PLL, MW N
300 kDa, Sigma-Aldrich, Munich, Germany), was used to improve in
situ cell labeling as previously described (Vreys et al., 2010). Brieﬂy,
a PLL stock solution of 1.5 mg/ml was prepared and stored at 5 °C.
Prior to injection, the stock solution was further diluted with a 0.9%
sodium chloride solution to 0.3 mg/ml and mixed with the MPIOs
(3.0 mg Fe/ml), yielding a ﬁnal MPIO concentration of 0.67 mg Fe/ml
with 0.045 mg PLL/ml. MPIO–PLL complexes were placed on a horizon-
tal shaker at 600 rpm for 60 min at room temperature to allow the
transfection agent to hybridize with the iron oxide particles. Following
preparation, MPIO–PLL complexes were directly used for stereotactic
injection.
Lentiviral vector
For genetic labeling of SVZ NSPC we used a previously described
LVv encoding both the eGFP and fLuc reporter proteins (LV–eGFP–
T2A–fLuc) (Vreys et al., 2010). The LVv was used at a concentration of
2.45 × 108 TU/ml.
Stereotactic injections of MPIO–PLL and LV–eGFP–T2A–fLuc
All surgical interventions were performed according to institu-
tional guidelines. Brieﬂy, mice were anesthetized by intraperitoneal
(IP) injection of a ketamine (50 mg/kg for MPIO–PLL injection and
75 mg/kg for LVv injection) (Anesketin; Eurovet NV/SA, Heusden-
Zolder, Belgium) + medetomidine (0.65 mg/kg for MPIO–PLL injec-
tion and 1 mg/kg for LVv injection) (Domitor; Pﬁzer Animal Health
S.A., Louvain-la-Neuve, Belgium)mixture and positioned in a stereotac-
tic head frame. Stereotactic coordinates to target the right lateral ventri-
cle forMPIO–PLL injectionwere as follows: AP 1.0 mm, La 0.75 mmand
DV 3.3 mm (relative to the bregma). Stereotactic coordinates to target
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AP 1.1 mm, La 1.4 mmandDV3.0 mm(relative to the bregma), and the
needle was then retracted until a depth of 2.3 mm for the second injec-
tion. A midline scalp incision was made to expose the skull, and a hole
was drilled in the skull using a dental drill burr. Thereafter, an automatic
micro-injector pump (kdScientiﬁc) with a 10 μl Hamilton syringe was
positioned above the exposed dura. A 26-gauge needle (Hamilton) for
MPIO–PLL injection or a 32-gauge needle (Hamilton) for LVv injections
was attached to the syringe and stereotactically placed through the in-
tact dura and positioned at the respective depth. The needle was left in
place for 1 min to allow for pressure equilibration. For MPIO–PLL injec-
tion, 2 μl of theMPIO–PLL solutionwas injected at a speed of 0.5 μl/min.
For LVv injection, 2 μl of LVv concentrate was injected at each injection
depth at a speed of 0.5 μl/min. Before ﬁnal needle retraction, a waiting
period of 5 min was kept in order to allow for pressure equilibration
and to prevent backﬂow of the injected MPIO–PLL or LVv suspension.
Next, the skin was sutured and a 0.9% NaCl solution was given subcuta-
neously in order to prevent dehydration while mice were placed under
a heating lamp to recover. Anesthesia was reversed by an IP injection of
atipamezol (Antisedan 5 mg/ml, Pﬁzer Animal Health S.A.). Immediate-
ly following the injection of MPIO–PLL or LV–eGFP–T2A–fLuc, mice
were randomly divided into a healthy control group or cuprizone treat-
ed group. Cuprizone treatment was initiated immediately following
injection.
Bioluminescence imaging, statistics and curve ﬁtting
In vivo BLI was performed according to previously optimized proce-
dures (Reekmans et al., 2011). A total of twenty C57BL/6J-Tyrc-2J/J mice,
tenwhich received the cuprizone diet and ten whichwere fed standard
rodent lab chow, were imaged weekly for a period of 12 weeks. Brieﬂy,
micewere anesthetized using 2% isoﬂurane (Isoﬂo®) in O2 at aﬂow rate
of 1 l/min. The head of each mouse was shaved before imaging. Mice
received an intravenous injection of D-luciferin (150 mg/kg body
weight dissolved in PBS; Promega Benelux) and were imaged imme-
diately thereafter for 5 min using an in vivo real-time φ-imager sys-
tem (Biospace). Data was acquired using the Photovision software
(v 2.7.5.1) and a photographic image was taken at the end of every ac-
quisition, allowing the BLI signal to be superimposed on this photo-
graphic image. For post-processing of BLI measurements, the M3
Vision software (v 1.4) was used. A region of interest (ROI) was manu-
ally deﬁned on the photographic image around the OB (0.113 cm2), the
SVZ (0.160 cm2), the splenium of the CC (sCC, 0.261 cm2) and a region
on the back of the animal located at the level of the two scapulae
(0.372 cm2). This last ROI was considered as background signal and
used as internal calibration allowing for comparison between different
acquisitions. BLI measurements of these respective ROIs were extracted
as photons/s/cm2/sr and ratios of the BLI signal coming from theOB, SVZ
or sCC over the BLI signal coming from the background region were cal-
culated. Results are expressed as mean of the group ± standard devia-
tion for each time point. In order to evaluate the accumulation of labeled
cells in the OB over time, data were ﬁtted to a sigmoid model using the
NONLIN software package (v 8.00). A two-way repeated measures
ANOVA was performed to investigate the time and group differences
between the ﬁrst and the last time point. A paired t-test was also used
to investigate the time difference between the ﬁrst and the last time
point within one group. Unpaired t-test was performed to investigate
group difference at week 2 p.i. and week 12 p.i. Statistical analysis of
the results was performed using SPSS (v 20.0.0) and a p-value b 0.05
was considered to be signiﬁcant.
Magnetic resonance imaging
MRI was performed at 400 MHz on a 9.4 Tesla MRI system (Biospec
94/20 USR, Bruker Biospin, Germany) using a circular polarized trans-
mit resonator and a quadrature receive surface coil. For in vivo MRIexperiments, a total of sixteen wt mice, ten which received the
cuprizone diet and six which were fed standard rodent lab chow,
were used. Anesthesia was induced by inhalation of 3% isoﬂurane
(Isoﬂo®) and maintained at 1.75% isoﬂurane in a mixture of 30% O2
and 70% N2O at a ﬂow rate of 600 ml/min. Mice were then ﬁxed in an
animal restrainer with ear bars and a tooth bar. Throughout image ac-
quisition, respiration rate and body temperature were continuously
monitored using a pressure sensitive pad and rectal probe respectively,
controlled by the pcSam software interface (SA Instrument Rents,
NY, USA). The monitoring system allowed us to maintain the respira-
tion rate at 110 ± 20 breaths/min and the body temperature to 37 ±
0.5 °C. Axial T2-weighted Fast Spin Echo images were obtained (5 slices,
slice thickness = 1 mm, matrix = 256 × 256, FOV = 25 × 25 mm2,
TR = 2500 ms, effective TE = 56 ms, echo train = 8, scanning time =
1 min 20 s). Next, high resolution (isotropic resolution of 78 μm) 3D
T2*-weighted gradient echo (GE) coronal images (matrix = 256 ×
196 × 128, FOV = 20 × 15.3 × 10 mm3 covering the entire brain,
TR = 40 ms, TE = 8 ms, 12° ﬂip angle, four repetitions, scanning
time = 16 min 43 s per repetition) were acquired. In vivo images
were acquired after 4 weeks of cuprizone treatment (w4), 4 weeks of
cuprizone treatment and 2 weeks of recovery (w4 + 2) or 4 weeks
of cuprizone treatment and 8 weeks of recovery (w4 + 8), corre-
sponding to 4, 6, and 12 weeks post-injection of MPIOs into the lat-
eral ventricle.
MR image analysis
The hypo-intense MPIO contrast in MR images was quantiﬁed using
a semi-automatic image analysis workﬂow, previously developed for
quantiﬁcation of MRI reporters (Vande Velde et al., 2011, 2012b).
First, individual repetitions were registered one-by-one to the ﬁrst
frame and then averaged. A cuboidal volume of interest (VOI) covering
the central region of OB in the right hemisphere was once deﬁned on a
reference image (template) in Paxinos space (MacKenzie-Graham et al.,
2004) andmirrored around themid-sagittal plane of the template. Sub-
sequently, corresponding bilateral OB VOIs from the right (ipsilateral
to MPIO injection,) and left (contralateral to MPIO injection) hemi-
spheres in each of the 3D data sets were automatically delineated by af-
ﬁne registration with the reference template image (Maes et al., 1997).
To avoid acquisition related confounding effects like within scan inten-
sity variations all images are ﬁrst corrected for the RF inhomogeneity
induced-bias ﬁeld using a method as described by Likar et al. (2001).
To facilitate comparison of signal intensities between time points and
among animals, MR intensities from VOI were normalized to their con-
trol region in contra-lateral OB (Meier andGuttmann, 2003). The above-
described image analysis steps were fully automated, with identical
parameter setting for all images in the given study, which eliminate
subjective comparison and ensure reproducible assessment. For qualita-
tive visualization, minimum intensity projections (mIPs) for each 3D
data were generated by merging the minimum intensities over 10 sag-
ittal slices, at the level where the RMS enters theOB. ThesemIPS are free
from intensity and position variations, thereby facilitating objective
comparison of similar image planes between time points and animals.
To visualize altered migration to demyelinated regions, mIPS along cor-
onal sectionwere also created at the level of the spleniumof CC (4 slices,
anterioposterior coordinates:−1.2 mmup to−1.5 mm, relative to the
bregma).
Statistical analysis
For quantitative assessment of MPIO labeled NPSC migration to the
OB, intensity histograms from ipsi- and contralateral hemispheres are
constructed from intensity normalized MR signal intensities. Using
two-sidedMann–Whitney U tests on the histogram values, the contrast
difference is statistically assessed (p-value b 0.05). In addition, the
bilateral contrast difference is quantiﬁed using the error weighted
Fig. 1. Setup and validation of the cuprizone mouse model. Representative immunoﬂuo-
rescence images taken at the level of the splenium of the corpus callosum of a control
mouse (Control, top row), of a mouse following four weeks on a 0.2% cuprizone diet
(w4, middle row) and of a mouse after four weeks on a 0.2% cuprizone diet followed by
8 weeks of recovery on standard rodent chow (w4 + 8, bottom row). The left column
shows myelin content by means of staining for myelin basic protein (MBP, red ﬂuores-
cence). The right column shows CC1+ oligodendrocytes (red ﬂuorescence) and cell densi-
ty in the CC by means of TOPRO-3 staining (false color, blue ﬂuorescence, scale bar =
50 μm). The splenium is indicated by thin white lines.
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2012b):
EWD ¼ μcontrol−μ testσcontrolﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ncontrol
p
where, μ, σ and N correspond to the mean, standard deviation and the
number of voxels of the OB VOI. Positive and large EWD value indicates
a strong hypo-intense contrast in the ipsilateral hemisphere, where la-
beled cells were expected to accumulate. EWD measures from control
and experimental groups were compared using a Kruskal–Wallis test.
Measures from different time points were compared using a Wilcoxon
signed-rank test. A p-value b 0.05 was considered to be signiﬁcant.
Histological analyses and quantiﬁcation
Histological analyses were performed according to previously opti-
mized procedures (Praet et al., 2012). Twelve weeks after MPIO–PLL
or LVv injection, mice were deeply anesthetized via an intraperitoneal
injection pentobarbital (60 mg/kg, Nembutal, Ceva Sante Animale)
and transcardially perfused with ice cold PBS and perfused-ﬁxed with
4% paraformaldehyde in 0.1 M PBS (pH 7.4). Complete animal heads
were post-ﬁxed overnight in 4% paraformaldehyde and whole brains
were then surgically removed and freeze-protected by passing through
a sucrose gradient (2 h at 5%, 2 h at 10% and overnight at 20%) after
which they were frozen in liquid nitrogen and stored at −80 °C until
further processing for histological analysis. Consecutive 10 μm-thick
cryosections were prepared from the OB, as well as from the front of
the injection site until the splenium, using a microm HM500. Slides
were screened by direct ﬂuorescence microscopy in order to locate
MPIO-containing or eGFP-expressing cells. The number eGFP positive
cells in the OB was quantiﬁed within a subset of 15 consecutive slices
taken in the middle of the OB, by two independent observers, blinded
to the experimental groups. Groups were compared using a Mann–
Whitney U test with a p-value b 0.05 considered to be signiﬁcant.
Further immunoﬂuorescence analysis was performed using the follow-
ing antibodies: a rabbit anti-GFAP (Abcam, ab7779, 1/1000 dilution) in
combination with a AF555-labeled donkey anti-rabbit secondary anti-
body (Invitrogen, A31572, 1/1000 dilution), a rabbit anti-IBA1 (Wako,
019-19741, 1/200 dilution) in combination with a AF555-labeled
donkey anti-rabbit secondary antibody (Invitrogen, A31572, 1/1000
dilution), a chicken anti-MBP antibody (Millipore, AB9348; 1/200 dilu-
tion) in combinationwith a DyLight549 donkey anti-Chicken secondary
antibody (Jackson ImmunoResearch, 703-506-155; 1/1000 dilution),
a mouse anti-APC/CC1 antibody (Calbiochem, OP80; 1/200 dilution) in
combination with an AF555-labeled goat anti-mouse secondary anti-
body (Invitrogen, AF21425; 1/300 dilution), a mouse anti-NeuN anti-
body (Millipore, MAB377; 1/200 dilution) in combination with an
AF555-labeled goat anti-mouse secondary antibody (Invitrogen,
AF21425; 1/300 dilution). Slides were counterstained using TOPRO-3
(Invitrogen, T3605, 1/200 dilution). Following staining, sections were
mounted using ProlongGoldAntifade (Invitrogen, P36930). Fluorescence
image acquisition was performed using a standard research ﬂuorescence
microscope (Olympus Bx51 ﬂuorescence microscope) equipped with
an Olympus DP71 digital camera. Olympus cellSense Software (v 1.4)
was used for wideﬁeld image acquisition or automated acquisition of op-
tical Z-stacks. Z-stacks were deconvoluted using the cellSense Wiener
deconvolution algorithm and a mean intensity projection was made in
order to obtain clear single-plane images.
Results
Setup and validation of the cuprizone mouse model
In this study we used the cuprizone model to induce both CNS de-
myelination and remyelination. In this setup, mice ﬁrst undergo acutedemyelination during 4 weeks of cuprizone intoxication followed by
8 weeks of recovery. In a ﬁrst experiment, we histologically validated:
(i) oligodendrocyte loss and demyelination following 4 weeks of
cuprizone treatment, and (ii) the reappearance of oligodendrocytes
and remyelination after 8 weeks of recovery. As shown by staining for
myelin basic protein (MBP) in Fig. 1, female wt C57BL6/J mice that
were on a 0.2% cuprizone diet for 4 weeks (w4) displayed severe de-
myelination in the splenium as compared to healthy control animals
(Control). At this time-point, nuclear TOPRO-3 staining indicated an ex-
cessive cell inﬂux (mainly composed of microglia/macrophages, data
not shown), while most oligodendrocytes had disappeared, as shown
by the absence of staining for CC1+ oligodendrocytes. On a side note,
the excessive cell inﬁltration, combined with edema resulting from
the inﬂammatory reaction, results in a thickening of the splenium at
week 4 (the splenium is indicated by thewhite lines). However, follow-
ing 8 weeks of recovery (w4 + 8), inﬂammatory cell accumulation
disappeared, as noted by reduced nuclear staining by TOPRO-3. At this
time-point, CC1+ oligodendrocytes reappeared and nearly complete
endogenous remyelinationwas observed, as shown by staining forMBP.MRI analysis ofMPIO-labeled SVZ NSPCmigration to the OB during de- and
remyelination in the cuprizone model
In order to investigatewhether SVZ NSPCs display normalmigratory
behavior during cuprizone-induced de- and remyelination, the follow-
ing experiment was performed. SVZ NSPCs of the right lateral ventricle
were labeled by intraventricular injection of MPIOs. FollowingMPIO in-
jection, mice were immediately put on a cuprizone-supplemented diet
for 4 weeks to induce inﬂammation and demyelination, followed by
8 weeks of recovery. In vivo longitudinal MRI of both healthy control
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after MPIO injection (w4, w4 + 2 and w4 + 8 respectively). The accu-
mulation of MPIO-labeled cells over time in the OB of both the healthy
and cuprizone treatedmice is visualized on representativeminimum in-
tensity projections (mIPs) of T2*-weighted images as hypo-intense
(dark) contrast spots (Fig. 2A, images shown are from 1 representative
mouse per group). In both the healthy control group (n = 6) and the
cuprizone treated group (n = 10), hypo-intense contrast can be detect-
ed along the injection tract, at the level of the ventricles, along the RMS
and in the OB of the ipsilateral (right) hemisphere. An accumulation of
hypo-intense contrast over time can be visually appreciated in the OB
of the ipsilateral hemisphere, however no hypo-intense contrast is ob-
served in theOBof the contralateral hemisphere. Additionally,we quan-
tiﬁed the accumulation of MPIO-labeled NSPCs in the OB over time to
investigate the effect of cuprizone administration on the constitutive
migration of NSPCs from the SVZ towards the OB. VOIs were taken in-
side the OB in both hemispheres as shown in Fig. 2B, and intensity his-
tograms from these VOIs are shown in Fig. 2C (histograms correspond
to the same animal in Fig. 2A). The histograms of the ipsilateral hemi-
sphere OB at each time point for both the control and cuprizone treated
groups, showed signiﬁcant (p b 0.05) hypo-intense voxels in themajor-
ity of animals (14/16 at w4, 16/16 at w4 + 2 and 14/16 at w4 + 8),
reﬂecting the presence of MPIO-induced hypo-intense contrast within
the ipsilateral hemisphere OB. Fig. 2D shows the comparison of EWD
measurements over time, and between the cuprizone treated group
and the control group. A signiﬁcant (w4 vs. w4 + 8: p = 0.005; w6
vs. w4 + 8: p = 0.017) accumulation of hypo-intense contrast in theFig. 2.MRI quantiﬁcation ofMPIO-labeled SVZ NSPCmigration towards the OB. (A) Representat
MPIO injection (w4, w4 + 2 and w4 + 8 respectively). Images shown are from a representati
rows) and from a representativemouse after a 4-week 0.2% cuprizone treatment followed by 8
trast (indicated by thewhite arrows) in the ipsilateral side of lateral ventricle injection showsm
MPIOs in the OB. (B) Representative VOIs were automatically generated by our pipeline in the
tiﬁcation of hypo-intense voxel load in the OB (left: coronal, middle: axial, right: sagittal plane
lateral to the MPIO injection) of the corresponding control mouse and cuprizone treated
statistically different and reveal a higher number of hypo-intense voxels in the ipsilateral OB. (D
group) and per time point, indicate no difference between both groups at any time points. How
(ns: no signiﬁcance, *: p-value b 0.05, **: p-value b 0.005, ***: p-value b 0.001).ipsilateral OB over time was noted in both groups. However, no differ-
ence was detected between the cuprizone-treated group and the con-
trol group at any time points (w4: p = 0.515; w4 + 2: p = 0.233;
w4 + 8: p = 0.386). In summary, the qualitative and quantitative as-
sessments of MR images suggest that constitutive migration of MPIO-
labeledNSPCs from the SVZ towards theOB is not likely impaired during
4 weeks of cuprizone-induced demyelination and subsequent 8 weeks
of recovery/remyelination.
Histological validation of MPIO-labeled SVZ NSPC migration to the OB
during de- and remyelination in the cuprizone model
Following the above-described results, we histologically validated
theuptake ofMPIOs by cells in and around the SVZ and their subsequent
migration to the OB. Representative IBA1 (microglia), GFAP (astro-
cytes), NeuN (neurons), and CC1 (oligodendrocytes) immunoﬂuores-
cence images in Fig. 3A show the SVZ of both the healthy control mice
and cuprizone treated mice at week 12 post-MPIO labeling (i.e. follow-
ing4 weeks of cuprizone treatment and 8 weeks of recovery). No differ-
ences were observed between healthy control mice and cuprizone
treated mice. Most MPIOs in the SVZ are internalized by IBA1+ microg-
lia, with few MPIOs found to co-localize with GFAP+ cells. Although
GFAP is often used as a marker for astrocytes, it is also known to be
expressed by SVZ NSPCs (Doetsch et al., 1999). Therefore, it is not un-
likely that MPIO+ GFAP+ cells in the SVZ represent, at least partially,
MPIO-labeled SVZ NSPCs. Rarely, but not absent, MPIOs were found to
co-localize with NeuN+ neurons and CC1+ oligodendrocytes in closeive sagittalmIPs of 3D gradient-echoMR images acquired in vivo atweeks 4, 6 and 12 post-
ve age-matched control mouse injected with MPIOs in the lateral ventricle (Control, 2 top
weeks of recovery on a regular rodent diet (Cuprizone, 2 bottom rows). Hypo-intense con-
igration from the injected area through the RMS and subsequent accumulation over time of
native space of MR images (blue: contralateral OB, red; ipsilateral OB) and used for quan-
s). (C) Histograms of image intensities extracted from VOIs (blue: contralateral, red: ipsi-
mouse as shown in panel A. Histograms from the contralateral and ipsilateral OB are
) Boxplots of EWDvalues per experimental group (green: control group, orange: cuprizone
ever, an accumulation of hypo-intense contrast in the ipsilateral OB overtime was noted.
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we also performed immunoﬂuorescence staining for NeuN, IBA1 and
GFAP on section from the OB of control and cuprizone-treated mice at
week 12 post-MPIO labeling of SVZ NSPC (i.e. following 4 weeks of
cuprizone treatment and 8 weeks of recovery). Again, no differences
were observed between healthy control mice and cuprizone treated
mice. While MPIOs were frequently found to co-localize with NeuN+
neurons, thereby conﬁrming the observed migration of SVZ NSPC-
derived neuroblasts, MPIOs were also found in IBA1+ microglia and –
although to a lesser extent – in GFAP+ cells. Even though further inves-
tigation is needed, the latter might indicate that SVZ NSPC migration
and differentiation towards the OB is a highly dynamic cell process
with multiple cell types or cell stages involved.
MRI reveals no migration of MPIO-labeled SVZ NSPCs towards the
demyelinated splenium in the cuprizone mouse model
Within the same experimental setup as described above, we addi-
tionally investigated whether SVZ-derived MPIO-labeled NSPCs migrate
towards the demyelinated splenium following cuprizone treatment
and whether or not they play a role in the renewal of the mature
oligodendrocyte pool during remyelination. Visual inspection of T2-
weighted images revealed a hypo-intense (darker) contrast coming
from the splenium, characteristic of myelin tissue, in control animals
at each measured time point. In contrast, the cuprizone treated group
displayed a clear hyper-intense contrast in the splenium after 4 weeks
of cuprizone treatment (w4) and after 4 weeks of cuprizone treat-
ment and 2 weeks of recovery (w4 + 2), reﬂecting demyelination of
the splenium and concomitant inﬂammation (Fig. 4A). However, after
4 weeks of cuprizone treatment and 8 weeks of recovery (w4 + 8), the
splenium displayed a similar contrast in the cuprizone-treated group
as compared to the control group, which indicates that remyelination
had occurred in the cuprizone treated group (Fig. 4A). In addition,
axial mIPs created from 3D gradient echo MR images at the level of
the splenium were visually inspected and no hypo-intense spots could
be detected at w4, w4 + 2 and w4 + 8 post-injection in the cuprizone
treated group, suggesting that nomigration of SVZMPIO-labeled NSPCs
towards this area had occurred (Fig. 4B). Hypo-intense contrast how-
ever could be observed in the ventricles as MPIOs spread along the
brain via the cerebro-spinal ﬂuid, and as such the latter was not consid-
ered to be due to genuinemigration of SVZNSPCs. Fig. 4C shows the his-
tological analysis of both the control and cuprizone treated groups at
week 12 post-injection (w12). MPIO+ cells apparently did not migrate
into the splenium as no MPIOs could be detected within these regions.
MPIOs near the injection tract are shown as a positive control (PC) to il-
lustrate howMPIOs can be identiﬁedwithin the CNS. All together, these
results suggest that SVZ-derived NSPCs are most likely not involved in
the replenishment of themature oligodendrocyte pool and the associat-
ed remyelination of the splenium.
In situ labeling of SVZ NSPCs with an eGFP–Luciferase encoding LVv
conﬁrms the absence of SVZ NSPC migration to the splenium in the
cuprizone mouse model
In a complementary experimental setup we used a genetic labeling
approach to further characterize/investigate the ﬁndings from particle-
based NSPC labeling. As we cannot rule out the fact that MPIOs taken
up by SVZ NSPCs become diluted upon (potential) high proliferation
and differentiation into oligodendrocytes during remyelination in the
cuprizone mouse model, we here genetically labeled SVZ NSPCs usingFig. 3.Histological validation of MPIO-labeled SVZ NSPCmigration to the OB. Representative im
healthy control animals (Control) and mice that received a 0.2% cuprizone diet for 4 weeks foll
time shows a general overview of the injection spot at a lowmagniﬁcation (scale bar = 50 μm
right picture (scale bar = 10 μm). Cell nuclei were stained using TOPRO-3 and are shown in b
(IBA1, GFAP, NeuN and CC1) are shown in red (red ﬂuorescence).a lentiviral vector encoding both the eGFP and Luciferase reporter pro-
teins. The latter allows reproducible tracking of not only the labeled
NSPCs themselves, but also their offspring. For this, in albino C57BL/6
mice SVZ NSPCs were in situ labeled by injection of an eGFP/fLuc LVv
and either: (i) used as control (n = 10), or (ii) subjected to a 0.2%
cuprizone diet for 4 weeks starting on the day of LVv injection and left
to recover on a normal diet for 8 weeks (n = 10). Mice were imaged
weekly during the 12-week observation period in order to monitor
SVZ-derived NSPC migration towards the OB and/or the demyelinated
splenium. As shown by the representative images at w4, w4 + 2 and
w4 + 8 in Fig. 5A, no large BLI signal could be detected caudally to
the injection site (i.e. the area of the splenium of the sCC), while a dis-
tinct BLI signal could be observed in the SVZ and an overtime increasing
BLI signal in the OB. In order to quantify putative migration of fLuc-
labeled cells from the SVZ towards the sCC, we extracted the BLI signal
coming from the background (BG), SVZ and sCC ROIs, as depicted in
Fig. 5A, and plotted the ratios of the BLI signal emanating from the
SVZ and the sCC, over the background signal (Figs. 5B and C, respective-
ly). The BLI signal in the SVZ remains stable over time for both the
healthy control group (p = 0.7) or cuprizone-treated group (p =
0.301), and no signiﬁcant differences were noted between the overall
BLI signal in the cuprizone-treated group as compared to the healthy
control group at week 2 p.i. (p = 0.077), nor at week 12 p.i. (p =
0.071) (Fig. 5B). The same observation was made in the sCC as the BLI
signal remained stable over time for both the control group (p =
0.199) and cuprizone treated group (p = 0.077). Again, no signiﬁcant
differences were detected between control and cuprizone-treated
groups at week 2 p.i. (p = 0.983) nor at week 12 p.i. (p = 0.444). The
latter indicates that fLuc–eGFP labeled cells do not accumulate in the
sCC over time (Fig. 5C). Furthermore, it should be noted that: (i) the
BLI signal variation over time observed in the sCC is similar to the one
observed at SVZ, and (ii) the BLI signal detected in the sCC corresponds
to the initial residual value detected in the OB before detection of mi-
grating cells (a ratio OB/background of about 150). Therefore we can
conclude that the BLI signal observed in the sCC ROI is likely due to
scattered light coming from the transfection area (the SVZ and adjacent
parenchyma), as these two ROIs are close in space, and hence nomigra-
tion of SVZ-derived cells towards the sCC could be detected bymeans of
in vivo BLI after in situ genetic labeling of SVZNSPCs. Furthermore, while
histological analysis conﬁrmed the presence of eGFP-expressing cells in
the SVZ and the surrounding parenchyma, no eGFP-expressing cells
were observed in the splenium of the CC at 12 weeks after injection in
both the control and cuprizone-treated groups (Fig. 6A), thereby
conﬁrming the absence of cell migration from the SVZ to the sCC during
remyelination in the cuprizone mouse model.
In situ labeling of SVZ NSPCs with an eGFP–Luciferase encoding LVv reveals
increased migration of SVZ NSPC towards the OB in the cuprizone mouse
model
Although analysis of SVZ NSPC-derived neuroblast migration to-
wards the OB was originally included as a control to conﬁrm efﬁcient
LVv-mediated transduction of SVZ NSPCs (Fig. 5A), we noted signiﬁcant
differences between control and cuprizone-treated mice. In order to
quantify migration of fLuc-labeled cells from the SVZ towards the OB,
we extracted the BLI signal coming from the OB ROI, as depicted in
Fig. 5A, and plotted the ratio of the BLI signal emanating from the OB
over the background signal (Fig. 5D). Effective migration of fLuc labeled
cells towards the OB can be appreciated by the sigmoidal distribution
of the BLI signal over time for both the control and cuprizone groupsmunoﬂuorescence images taken at the site of MPIO injection (A) or in the OB (B), for both
owed by 8 weeks of recovery on standard rodent chow (Cuprizone). The left picture each
), while the area inside the white rectangle is then shown at a higher magniﬁcation in the
lue (false color), MPIOs are shown in green (false color) and the corresponding markers
Fig. 4.MPIO-labeled SVZNSPCs do notmigrate towards the demyelinated splenium in the cuprizonemousemodel. (A) Representative axial T2-weighted images acquired in vivo atweeks
4, 6 and 12 p.i. (w4, w4 + 2 and w4 + 8). Images shown are from an age-matched control mouse injected with MPIOs in the lateral ventricle (Control, top row) and from a mouse that
received a 4-week cuprizone treatment followed by 8 weeks of recovery on a regular rodent diet (Cuprizone, bottom row). Arrows point at hyper-intensity of the CC indicating demye-
lination/inﬂammation due to cuprizone administration. (B) Representative axial mIPs of 3D gradient-echo MR images acquired in vivo at weeks 4, 6 and 12 p.i. (w4, w4 + 2 and w4 + 8
respectively) indicate the absence of hypo-intense contrast at the level of the spleniumof theCC. (C) Representative blue-ﬂuorescence images taken at the level of the spleniumof amouse
that received a 0.2% cuprizone diet for 4 weeks followed by 8 weeks of recovery on standard rodent chow (Cuprizone) and an agematched control mouse (Control, scale bar = 100 μm).
A positive control (PC) of MPIOs near the injection tract is shown to illustrate how MPIOs can be identiﬁed in the CNS (scale bar = 200 μm).
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signal overtime (p b 0.001) for the cuprizone-treated group and the
control group (p = 0.049). While no signiﬁcant differences were
found between the control group and the cuprizone-treated group at
week 2 post-LVv injection (p = 0.206), a higher BLI signal was found
in the cuprizone-treated group compared to the control group at week
12 post-LVv injection (p = 0.002). Moreover, the migration behavior
of the cuprizone-treated group differs from the control group and
this is reﬂected by a time and group interaction (p = 0.001). Finally,
we performed histological quantiﬁcation of the eGFP positive cells
present in the OB at week 12 post-LVv injection in both the control
and cuprizone-treated groups (Fig. 6A) and conﬁrmed the higher num-
ber of LVv-labeled NSPCs arriving in the OB of cuprizone-treated mice
as compared to control mice (Fig. 5E, p = 0.026). Furthermore, immu-
noﬂuorescence staining for both groups conﬁrmed that eGFP-labeled
cells residing the OB co-localized with the neuronal marker NeuN, but
not with IBA1 (microglia) or GFAP (astrocytes, Fig. 6B). In agreement
with the higher BLI signal observed in the SVZ of cuprizone-treated
mice as compared to control mice (see above, Fig. 5B), our results sug-
gest an increased proliferation of NSPCs in the SVZ and eventually ahigher number of NSPCs that migrate to the OB of cuprizone-treated
mice.
Discussion
We investigated the contribution of endogenous SVZ NSPCs to the
remyelination process in the cuprizone mouse model by means of
MRI- and BLI-based in vivo longitudinal monitoring of SVZ NSPC migra-
tion. Using these techniques, our data suggest that the origin of cells re-
sponsible for remyelination of the CC in the cuprizone mouse model is
not the SVZ NSPC compartment, despite preceding observations of
SVZ cell proliferation and migration following cuprizone treatment.
The exact origin of the progenitor cells responsible for remyelination
in the cuprizone model thus needs to be further investigated.
Previously, it has been suggested that SVZ-derived NSPCs are in-
volved in remyelination of the corpus callosum following cuprizone-
induced demyelination (Chen et al., 2012; Kipp et al., 2009; Mason
et al., 2000; Petratos et al., 2004). However, we questioned whether
SVZ-derived progenitor cells really are the cell population responsible
for the observed remyelination in the cuprizone model as: (i) these
Fig. 5. LVv-labeled SVZ NSPCs do notmigrate towards the demyelinated splenium but show an increasedmigration towards the OB in the cuprizonemousemodel. (A) Representative BLI
images of amouse injectedwith the eGFP-fLuc encoding LVv andwhich received either a control diet for 12 weeks (Control) or a cuprizone diet for 4 weeks followed by 8 weeks recovery
on standard rodent chow (Cuprizone). Images were acquired at 4, 6 and 12 weeks p.i. (w4, w4 + 2 and w4 + 8). The used ROI for the olfactory bulb (OB), subventricular zone (SVZ),
splenium of the corpus callosum (sCC) and background (BG) is also shown. (B) The mean of the subventricular zone BLI signal ratio (BLISVZ/BLIBG) during the 12 week period p.i. is
shown for healthy control mice and for cuprizone treatedmice (4 weeks of cuprizone diet followed by 8 weeks of recovery). (C) Themean of the sCC BLI signal ratio (BLISCC/BLIBG) during
the 12 week period p.i. is shown for healthy control mice and for cuprizone treatedmice (4 weeks of cuprizone diet followed by 8 weeks of recovery). (D) The mean of the OB BLI signal
ratio (BLIOB/BLIBG) during the 12 week period p.i. is shown for healthy controlmice and for cuprizone treatedmice (4 weeks of cuprizone diet followed by 8 weeks of recovery).Migration
of fLuc labeled cells towards the OB can be appreciated by the sigmoidal distribution of the BLI signal over time. (E) Histological quantiﬁcation of the number of eGFP positive cells found
per lowmagniﬁcation picture of the OB for both healthy control mice (Control) and for cuprizone treatedmice (4 weeks of cuprizone diet followed by 8 weeks of recovery (Cuprizone)).
(*: p-value b 0.05).
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allow to longitudinal follow-up the highly dynamic processes of cell
proliferation, migration, differentiation and eventually remyelination,
(ii) many NG2+ OPCs are present throughout white and gray matter
in the adult CNS and these are actively proliferating throughout adult-
hood (Dawson et al., 2003), and (iii) this widespread population of
PDGFR-α/NG2+ oligodendrocyte progenitor cells was shown to be
able to differentiate into oligodendrocytes and Schwann cells in re-
sponse to a demyelinating insult (Zawadzka et al., 2010). Therefore, in
this study we investigated the involvement of SVZ-derived NSPCs dur-
ing remyelination of the splenium following cuprizone treatment by
means of MRI and BLI.
Additionally, we longitudinally investigated the constitutive migra-
tion of SVZNSPCs towards the OB in vivo. WhileMRI analysis did not in-
dicate signiﬁcant differences between the healthy control group and the
cuprizone-treated group, BLI analysis indicated a signiﬁcant alterationof the SVZ NSPC migration from the SVZ to the OB in cuprizone-
treated mice as compared to healthy control mice. Given the preceding
observations that cuprizone-induced CNS inﬂammation induces cell
proliferation in the SVZ at early stages post-administration (Mason
et al., 2000; Silvestroff et al., 2010) and that CNS inﬂammation can pro-
mote endogenous neurogenesis (Gonzalez-Perez et al., 2012), it is not
unlikely that the latter might have caused signiﬁcant proliferation of
non-transduced and LVv-transduced NSPCs in the SVZ, thereby poten-
tially explaining the increased BLI signal and number of eGFP+ neurons
we observed in the OB of cuprizone-treated mice as compared to
healthy control mice. These ﬁndings are supported by the study of
Picard-Riera et al., who observed an increased migration of SVZ NSPCs
towards the OB following EAE induction (Picard-Riera et al., 2002). In
contrast to the results obtained using the BLI approach, wewere unable
to visualize a cuprizone-induced increase in SVZ NSPC migration to-
wards the OB by means of MRI. However, the latter can be explained
Fig. 6.Histological validation of LVv-labeled SVZ NSPC migration to the OB. (A) Representative histological images at 12 weeks following injection of an eGFP–fLuc encoding LVv in both
control mice (Control) or mice fed a 0.2% cuprizone diet for 4 weeks followed by 8 weeks of recovery. eGFP positive cells can be observed in the olfactory bulb, the SVZ and parenchyma
near the injection site (SVZ), but not in the splenium of the CC caudal to the injection site. (B) Representative histological images of the olfactory bulb at 12 weeks following injection of an
eGFP–fLuc encoding LVv in both a control mouse (Control) or mice fed a 0.2% cuprizone diet for 4 weeks followed by 8 weeks of recovery. The left image shows a general overview of the
olfactory bulb at a lowmagniﬁcation (scale bar = 50 μm) while the area inside the white rectangle is then shown at a higher magniﬁcation in the right image (scale bar = 10 μm). Cell
nuclei were stained using TOPRO-3 and are shown in blue (false color), eGFP–fLuc transduced cells are shown by their green ﬂuorescence and the corresponding cell-speciﬁc markers
(IBA1, GFAP and NeuN) are shown in red (red ﬂuorescence).
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following cell proliferation (Walczak et al., 2007), which is in contrast
with the LVv transduction approachwhere all progeny of initially trans-
duced cells remains labeled.
While previous reports have described visualization of NSPC mi-
gration during the ﬁrst days to weeks post-MPIO labeling, we only
observed the start ofmigration at fourweekspost-MPIO injection.How-
ever, several explanations can be suggested to explain this observation.
First, Nieman et al. (2010) observed MPIO-labeled NSPC migration over
the RMS already at 1 day post-injection. In contrast to our study, where
MPIOwere injected into the lateral ventricle, in their studyMPIOs were
directly injected into the SVZ, possibly transfecting also neuroblast com-
mitted NSPCs. Another possible explanation could be that MPIOs areinjected too far to the back, which has been suggested to result in
MPIO retention in the choroid plexus (Granot et al., 2011). However,
although in our study we did occasionally observe MPIOs in the cho-
roid plexus, most of the MPIOs were near the injection tract and with-
in the ventricle wall of the SVZ. In addition, it is currently also well
described that differentMPIO coatings can inﬂuence NSPCMPIO uptake
and therefore might inﬂuenceMPIO-labeled NSPC migration (Tang and
Shapiro, 2011; Vreys et al., 2010).
Finally, regarding both methods used for imaging SVZ NSPC migra-
tion, several differences can be noted between the two techniques.
(i) In agreement with a previous observation by Nieman et al. (2010),
in our study we also observed that around 30% of MPIOs in the OB col-
locate with IBA1+ microglia, which is indicative of MPIO phagocytosis
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ulation. (ii) There is also a difference in cell labeling speed between the
BLI andMRI approach.While followingMPIO injection, a continuous la-
beling of NSPCsmight occur during thewhole experiment, LVv injection
results of in an immediate (hours to days) transduction of SVZ NSPCs
(Geraerts et al., 2006). For the latter it also has to be noted that, inde-
pendent of the relatively fast transduction, stable expression of the in-
troduced reporter genes is known to take up to 2 weeks (Baekelandt
et al., 2002). Likewise, it would be interesting to study LVv-mediated
transduction of SVZ NSPC with an MRI reporter gene, however this ap-
proach is currently suffering from low in vivo sensitivity (Vande Velde
et al., 2011, 2012b).
Conclusions
In summary, we demonstrate using non-invasive imaging
modalities – and conﬁrm by histological analyses – that: (i) normal
SVZ NSPC migration is altered following cuprizone treatment, and
(ii) SVZ NSPCs do not seem to leave the RMS following cuprizone treat-
ment and are therefore not responsible for the observed spontaneous
remyelination of the splenium. Nevertheless, the fact that cuprizone-
induced CNS inﬂammation and tissue damage is a trigger for increased
migration of SVZ NSPC migration to the OB might open new directions
for the identiﬁcation of factors promoting OB neurogenesis. On the
other hand, as inﬂammation induces proliferation of SVZ NSPC, one of
the main challenges in the nearby future will be – if possible – to
redirect their migration and or differentiation potential towards for ex-
ample oligodendrocytes. However, future studies combining both lon-
gitudinal analyses with an in-depth histological characterization of
SVZ NSPC fate will reveal if such a strategy is feasible to treat MS, or
whether therapeutic intervention should explore other resident stem/
progenitor populations.
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